MIR News and Press, Mirion Technologies Inc. Class A From 11/01/23

Mirion Technologies Inc. Class A (MIR) is expected to report for Q1 2024

Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the Baird Global Industrial Conference in Chicago, IL. The presentation will begin at 10:40 AM ET on Tuesday, November 7, 2023. The presentation will be ...

Mirion’s Chief Executive Officer, Thomas Logan, will reassume responsibilities of Medical Group President until permanent successor is named Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and...

Mirion (NYSE: MIR) announced today that it will release financial results for the third quarter of 2023 after market close on Wednesday, November 1, 2023. Following the news release, the company will host a conference call the next day, Thursday, November 2, 2023, at 12:00 pm ET to discuss the re...

High-Purity Germanium Detector Will Provide Key Insights into the Make-Up of the Metallic Asteroid Mirion Technologies (NYSE: MIR) , a leading provider of advanced radiation safety solutions, today announced its contribution to the Psyche mission, which launched from the agency's Ke...

2023-10-02 07:45:53 ET Summary Mirion Technologies is experiencing a contraction in valuation despite upward revisions in guidance and expected top-line growth. MIR operates in the information technology sector, focusing on radiation detection and monitoring services. The medi...

Sun Nuclear® Solutions Supporting Better Patient Care in Focus at ASTRO 2023 PR Newswire SunCHECK ® Platform Enhancements, New MRgRT QA Solutions, and More MELBOURNE, Fla. , Sept. 29, 2023 /PRNewswire/ -- Sun Nuclear , a Mirion Medical c...

Sun Nuclear SunSCAN™ 3D Water Scanning System Receives CE Marking PR Newswire Faster, Hyper-Accurate Commissioning and Beam Scanning Solution Now Available in Countries Requiring CE Marking MELBOURNE, Fla. , Sept. 28, 2023 /PRNewswire/ -- Sun...

HALIFAX, NS / ACCESSWIRE / September 27, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada and the USA for its infectious disease rapid tests. Currently the Company has two submissions filed with Health Canada and one subm...

HALIFAX, NS / ACCESSWIRE / August 30, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) has completed, with its Transfer Agent, the process and has received confirmation by the TSX.v as follows: "Further to the resumption of trading of the shares of MedMira Inc., (the "Company"), the Exchange adv...